Characterizing the Spectrum of Epigenetic Dysregulation Across Lymphoid Malignancies
- Author(s)
- Harrop, S; Dickinson, M; Johnstone, R; Prince, HM;
- Journal Title
- In: O'Connor, O.A., Ansell, S.M., Seymour, J.F. (eds) Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice
- Publication Type
- Book section
- Abstract
- Epigenetic dysregulation is frequent across lymphoid malignancies and contributes to lymphomagenesis and disease behavior. The epigenome plays a key role in guiding normal lymphocyte development via regulation of gene expression by DNA methylation and chromatin modification. Altered methylation patterns are frequently seen in lymphoid cancers while key epigenetic regulators have been recognized to be recurrently mutated in specific entities. Such epigenetic alterations have led to a better understanding of mechanisms of lymphomagenesis and have been incorporated into our modern lymphoma classifications. Into the future they will provide key therapeutic targets.
- Department(s)
- Clinical Haematology; Laboratory Research
- Publisher's Version
- https://doi.org/10.1002/9781119819950.ch3
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-20 06:08:18
Last Modified: 2024-08-20 06:56:56